0000899243-19-005463.txt : 20190301
0000899243-19-005463.hdr.sgml : 20190301
20190301163940
ACCESSION NUMBER: 0000899243-19-005463
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190227
FILED AS OF DATE: 20190301
DATE AS OF CHANGE: 20190301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HALKUFF DAWN
CENTRAL INDEX KEY: 0001743658
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38536
FILM NUMBER: 19650046
MAIL ADDRESS:
STREET 1: C/O XERIS PHARMACEUTICALS
STREET 2: 180 N. LASALLE ST., STE. 1800
CITY: CHICAGO
STATE: IL
ZIP: 60601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: XERIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001346302
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203352427
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 180 NORTH LASALLE STREET
STREET 2: STE 1800
CITY: CHICAGO
STATE: IL
ZIP: 60601
BUSINESS PHONE: 512-498-2670
MAIL ADDRESS:
STREET 1: 180 NORTH LASALLE STREET
STREET 2: STE 1800
CITY: CHICAGO
STATE: IL
ZIP: 60601
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-27
0
0001346302
XERIS PHARMACEUTICALS INC
XERS
0001743658
HALKUFF DAWN
C/O XERIS PHARMACEUTICALS, INC.
180 N. LASALLE STREET, SUITE 1810
CHICAGO
IL
60601
1
0
0
0
Stock Option (right to buy)
10.00
2019-02-27
4
A
0
20000
0.00
A
2029-02-27
Common Stock
20000
20000
D
25% of these shares shall vest on the first anniversary of the vesting commencement date, with the remainder vesting ratably over the following 36 months.
/s/ Beth Hecht, as Attorney-in-Fact
2019-03-01